Myoclonus-dystonia syndrome
- PMID: 21496608
- DOI: 10.1016/B978-0-444-52014-2.00041-0
Myoclonus-dystonia syndrome
Abstract
Myoclonus dystonia syndrome (MDS) refers to a group of heterogeneous nondegenerative clinical conditions characterized by the association of myoclonus and dystonia as the only or prominent symptom. The "core" of MDS is represented by inherited myoclonus-dystonia (M-D), a disorder with autosomal-dominant inheritance and reduced penetrance, beginning in early childhood with a relatively benign course, with myoclonus as the most predominant and disabling symptom. Alcohol responsiveness and psychiatric symptoms are characteristic features. Mutations in the epsilon-sarcoglycan gene (SGCE, DYT11) represent the major genetic cause, but M-D is genetically heterogeneous. In a variable proportion of M-D patients no mutation is found, and at least one other locus (DYT15) has been linked to the disease. Patients with primary dystonia, with or without the DYT1 mutation, may show irregular and arrhythmic jerky movements associated with dystonia. Usually dystonia is the prominent symptom and the myoclonic jerk involves the same body region; this condition, currently defined as "myoclonic dystonia," is included in the spectrum of MDS. Dopa-responsive dystonia due to mutation in the GTP-CH gene and vitamin E deficiency can present with a phenotype of dystonia and myoclonus in combination; both conditions should be considered in the diagnostic approach to patients since they are potentially treatable.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.J Med Genet. 2006 May;43(5):394-400. doi: 10.1136/jmg.2005.036780. Epub 2005 Oct 14. J Med Genet. 2006. PMID: 16227522 Free PMC article.
-
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.Nat Genet. 2001 Sep;29(1):66-9. doi: 10.1038/ng709. Nat Genet. 2001. PMID: 11528394
-
Genetic Aspects of Myoclonus-Dystonia Syndrome (MDS).Mol Neurobiol. 2017 Mar;54(2):939-942. doi: 10.1007/s12035-016-9712-x. Epub 2016 Jan 20. Mol Neurobiol. 2017. PMID: 26790671 Review.
-
Deep brain stimulation in myoclonus-dystonia syndrome.Mov Disord. 2004 Jun;19(6):724-7. doi: 10.1002/mds.20030. Mov Disord. 2004. PMID: 15197720
-
The monogenic primary dystonias.Brain. 2009 Aug;132(Pt 8):2005-25. doi: 10.1093/brain/awp172. Epub 2009 Jul 3. Brain. 2009. PMID: 19578124 Review.
Cited by
-
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia.Am J Hum Genet. 2015 Jun 4;96(6):938-47. doi: 10.1016/j.ajhg.2015.04.008. Epub 2015 May 14. Am J Hum Genet. 2015. PMID: 25983243 Free PMC article.
-
Substance of abuse and movement disorders: complex interactions and comorbidities.Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. doi: 10.2174/1874473711205030243. Curr Drug Abuse Rev. 2012. PMID: 23030352 Free PMC article. Review.
-
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome.Neurol Sci. 2023 Aug;44(8):2943-2945. doi: 10.1007/s10072-023-06803-y. Epub 2023 May 3. Neurol Sci. 2023. PMID: 37131084
-
Deciphering the Pathophysiological Mechanisms Underpinning Myoclonus Dystonia Using Pluripotent Stem Cell-Derived Cellular Models.Cells. 2024 Sep 10;13(18):1520. doi: 10.3390/cells13181520. Cells. 2024. PMID: 39329704 Free PMC article. Review.
-
The genetics of dystonia: new twists in an old tale.Brain. 2013 Jul;136(Pt 7):2017-37. doi: 10.1093/brain/awt138. Epub 2013 Jun 17. Brain. 2013. PMID: 23775978 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
